▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Eli Lilly And Co. Q3 22 Earnings Conference Call At 9:00 AM ET

By RTTNews Staff Writer ✉ | Published: 11/1/2022 6:00 AM ET

Eli Lilly And Co. (LLY) will host a conference call at 9:00 AM ET on Nov. 1, 2022, to discuss Q3 22 earnings results.

To access the live webcast, log on to https://investor.lilly.com/webcasts-and-presentations

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

U.S. Covid Metrics Signal Ease In Pandemic

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

Lilly To Expand Manufacturing Facility In North Carolina

Eli Lilly Announces FDA Acceptance Of SNDA For Jardiance For Chronic Kidney Disease

FDA Declines To Grant Accelerated Approval To Lilly's Alzheimer's Drug

Lilly, ProQR To Expand Licensing And Collaboration Deal For New Genetic Medicines

Eli Lilly Investor Conference Call At 9:00 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

GE HealthCare Q4 Profit Declines

Toyota Is World's Top-selling Automaker Again

Rao's Slow Simmered Soup, Chicken & Gnocchi Recalled

Daniele Intl Recalls Ready-to-Eat Sausage Products

Chevron Q4 Profit Up 25%, But Misses Estimates

ZLINE Expands Recall Of Gas Ranges

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Drizzilicious Mini Rice Cake Bites, Popcorn Recalled

Comcast Q4 Profit Edges Down, But Results Top Estimates

Meta To Reinstate Donald Trump's Facebook, Instagram Accounts

Almondy Chocolate Cake With Daim Recalled

Amazon Workers At UK Warehouse On Strike

Cidara: FDA Committee Recommends FDA Approve Rezafungin For Candidemia, Invasive Candidiasis

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment

Abbott Issues FY23 Earnings, Sales Growth View - Update

Lonza FY22 Profit Up, Lifts Dividend; Sees Higher FY23 Sales, Weak Margin; Plans CHF 2 Bln Buyback

Abbott Laboratories Q4 Profit Decreases, but beats estimates

Sartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales View

Resmed Inc Q2 Profit Increases, beats estimates

Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies

Biotech Stocks Facing FDA Decision In February 2023

Sartorius FY22 Prelim Earnings, Revenue Rise

Merck's KEYTRUDA Gets FDA Approval To Treat Stage IB, II, IIIA Non-small Cell Lung Cancer Patients

Landsec Completes Sale Of One New Street Square

Northrop Grumman Q4 Results Top Estimates; Initiates FY23 Outlook

Toyota Is World's Top-selling Automaker Again

TFS FINANCIAL CORP. Q1 income increases in line with estimates

Playtech Plc Projects FY22 Adj. EBITDA To Rise 26%

Eastern Bankshares Down 11% As Q4 Earnings Fell Shy Of Estimates

Philip Morris Int'l To Commercialize KT&G's Smoke-Free Products Outside South Korea

Ipsen: CHMP Recommends Not To Grant Marketing Authorization For Palovarotene As Treatment For FOP

Archer-Daniels-Midland Q4 Profit Increases, beats estimates

CNX Resources Corporation Q4 Income Climbs

Eisai : EMA Accepts MAA For Lecanemab As Treatment For Early Alzheimer's Disease

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment